Literature DB >> 1281400

Effects of a single haloperidol application to neonatal and early postnatal rats on the neurotransmitter content in the corpus striatum.

R Schwabe1, R Thiel, I Chahoud, D Neubert.   

Abstract

We investigated the influence of the dopamine antagonist haloperidol on the neurotransmitter content in the developing rat brain. Dopamine (DA), serotonin (5-HT) and the corresponding metabolites dopac, HVA and HIAA were determined in the corpus striatum of the rat between day 1 and day 21 pn by HPLC with electro-chemical detection. A consistent increase in the content of dopamine was found during postnatal development. The concentrations (ng/g wet tissue; mean +/- standard deviation) increased from 793 +/- 237 on day 1 pn to 4584 +/- 581 on day 21 pn, but remained still lower than in adult animals (9763 +/- 494). Similar results were found for the metabolites dopac and HVA. The content of dopac increased from 59 +/- 22 (day 1 pn) to 551 +/- 59 (day 21 pn) and the content of HVA from 53 +/- 18 (day 1 pn) to 419 +/- 41 (day 21 pn). Both metabolites were also about two times lower than in adult animals (dopac 1090 +/- 282, HVA 744 +/- 206). In contrast to dopamine and its metabolites we found no age-dependent changes in the content of 5-HT from day 1 pn (99 +/- 11) to day 14 pn (121 +/- 21). A remarkable increase in the content of 5-HT was seen from day 14 pn to day 21 pn (438 +/- 56), reaching almost adult levels (570 +/- 92). The metabolite HIAA was nearly three times higher on day 21 pn (610 +/- 123) than on day 14 pn (223 +/- 28) and two times higher than in adults (321 +/- 58).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1281400     DOI: 10.1007/BF01973388

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  21 in total

1.  Determination of nanogram amounts of homovanillic acid in the central nervous system with a rapid semiautomated fluorometric method.

Authors:  B H Westerink; J Korf
Journal:  Biochem Med       Date:  1975-02

2.  Feeding and drinking interactions after acute butyrophenone administration.

Authors:  N Rowland; D J Engle
Journal:  Pharmacol Biochem Behav       Date:  1977-10       Impact factor: 3.533

3.  The development of a patchy organization of the rat striatum.

Authors:  A J Lança; S Boyd; B E Kolb; D van der Kooy
Journal:  Brain Res       Date:  1986-06       Impact factor: 3.252

4.  Behavioral activation in rats increases striatal dopamine metabolism measured by dialysis perfusion.

Authors:  J D Salamone; R W Keller; M J Zigmond; E M Stricker
Journal:  Brain Res       Date:  1989-05-22       Impact factor: 3.252

5.  Developmental and age-related changes in D1-dopamine receptors and dopamine content in the rat striatum.

Authors:  O Giorgi; G De Montis; M L Porceddu; S Mele; G Calderini; G Toffano; G Biggio
Journal:  Brain Res       Date:  1987-10       Impact factor: 3.252

6.  Distribution of tritiated haloperidol in lactating and pregnant cows and ewes.

Authors:  G Ziv; J S Mishkinsky; Y Givant; O Buchman; F G Sulman
Journal:  Arch Int Pharmacodyn Ther       Date:  1974-11

7.  Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol.

Authors:  H Asper; M Baggiolini; H R Burki; H Lauener; W Ruch; G Stille
Journal:  Eur J Pharmacol       Date:  1973-06       Impact factor: 4.432

8.  Neurochemical effects of prenatal haloperidol exposure.

Authors:  F M Scalzo; R R Holson; B J Gough; S F Ali
Journal:  Pharmacol Biochem Behav       Date:  1989-12       Impact factor: 3.533

9.  Haloperidol and cerebral metabolism in the conscious rat: relation to pharmacokinetics.

Authors:  G Pizzolato; T T Soncrant; S I Rapoport
Journal:  J Neurochem       Date:  1984-09       Impact factor: 5.372

10.  Dopamine and preparatory behavior: II. A neurochemical analysis.

Authors:  J R Blackburn; A G Phillips; A Jakubovic; H C Fibiger
Journal:  Behav Neurosci       Date:  1989-02       Impact factor: 1.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.